Works matching IS 09509232 AND DT 2011 AND VI 30 AND IP 1

Results: 11

Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 77, doi. 10.1038/onc.2010.404

By:

Olanich, M E;
Moss, B L;
Piwnica-Worms, D;
Townsend, R R;
Weber, J D

Publication type:

Article

Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 54, doi. 10.1038/onc.2010.387

By:

Sevenich, L;
Werner, F;
Gajda, M;
Schurigt, U;
Sieber, C;
Müller, S;
Follo, M;
Peters, C;
Reinheckel, T

Publication type:

Article

4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A<sub>2</sub> and its receptor.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 106, doi. 10.1038/onc.2010.390

By:

Huang, R-Y;
Li, M-Y;
Hsin, M K Y;
Underwood, M J;
Ma, L T;
Mok, T S K;
Warner, T D;
Chen, G G

Publication type:

Article

Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 43, doi. 10.1038/onc.2010.391

By:

Savaskan, N E;
Seufert, S;
Hauke, J;
Tränkle, C;
Eyüpoglu, I Y;
Hahnen, E

Publication type:

Article

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 32, doi. 10.1038/onc.2010.389

By:

Wheeler, D S;
Barrick, S R;
Grubisha, M J;
Brufsky, A M;
Friedman, P A;
Romero, G

Publication type:

Article

Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 21, doi. 10.1038/onc.2010.395

By:

Liu, W;
Xin, H;
Eckert, D T;
Brown, J A;
Gnarra, J R

Publication type:

Article

CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 97, doi. 10.1038/onc.2010.383

By:

Takenobu, H;
Shimozato, O;
Nakamura, T;
Ochiai, H;
Yamaguchi, Y;
Ohira, M;
Nakagawara, A;
Kamijo, T

Publication type:

Article

MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 117, doi. 10.1038/onc.2010.403

By:

Azmi, A S;
Philip, P A;
Beck, F W J;
Wang, Z;
Banerjee, S;
Wang, S;
Yang, D;
Sarkar, F H;
Mohammad, R M

Publication type:

Article

Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 65, doi. 10.1038/onc.2010.394

By:

Di Marcotullio, L;
Greco, A;
Mazzà, D;
Canettieri, G;
Pietrosanti, L;
Infante, P;
Coni, S;
Moretti, M;
De Smaele, E;
Ferretti, E;
Screpanti, I;
Gulino, A

Publication type:

Article

The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 87, doi. 10.1038/onc.2010.396

By:

Neely, R J;
Brose, M S;
Gray, C M;
McCorkell, K A;
Leibowitz, J M;
Ma, C;
Rothstein, J L;
May, M J

Publication type:

Article

Towards novel paradigms for cancer therapy.

Published in:

Oncogene, 2011, v. 30, n. 1, p. 1, doi. 10.1038/onc.2010.460

By:

Pavet, V;
Portal, M M;
Moulin, J C;
Herbrecht, R;
Gronemeyer, H

Publication type:

Article